1. Home
  2. RVSB vs CRDL Comparison

RVSB vs CRDL Comparison

Compare RVSB & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Riverview Bancorp Inc

RVSB

Riverview Bancorp Inc

HOLD

Current Price

$5.21

Market Cap

110.8M

Sector

Finance

ML Signal

HOLD

Logo Cardiol Therapeutics Inc.

CRDL

Cardiol Therapeutics Inc.

HOLD

Current Price

$1.05

Market Cap

97.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVSB
CRDL
Founded
1923
2017
Country
United States
Canada
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
110.8M
97.3M
IPO Year
1993
N/A

Fundamental Metrics

Financial Performance
Metric
RVSB
CRDL
Price
$5.21
$1.05
Analyst Decision
Buy
Strong Buy
Analyst Count
1
2
Target Price
$7.00
$9.00
AVG Volume (30 Days)
48.8K
328.2K
Earning Date
01-26-2026
11-13-2025
Dividend Yield
1.54%
N/A
EPS Growth
361.12
N/A
EPS
0.22
N/A
Revenue
$52,756,000.00
N/A
Revenue This Year
$10.25
N/A
Revenue Next Year
$11.23
N/A
P/E Ratio
$23.64
N/A
Revenue Growth
15.20
N/A
52 Week Low
$4.74
$0.77
52 Week High
$6.59
$1.59

Technical Indicators

Market Signals
Indicator
RVSB
CRDL
Relative Strength Index (RSI) 53.50 59.15
Support Level $4.95 $0.94
Resistance Level $5.13 $1.03
Average True Range (ATR) 0.11 0.05
MACD 0.01 0.00
Stochastic Oscillator 90.14 85.71

Price Performance

Historical Comparison
RVSB
CRDL

About RVSB Riverview Bancorp Inc

Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

Share on Social Networks: